Skip to content

Clinical trials

Atherosclerosis trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Atherosclerosis Country / region: United Kingdom Clear all

87 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20033
20042
20051
20063
20072
20082
20092
20103
20115
20124
20133
20146
20165
20178
20185
20191
20206
20212
20226
20233
20246
20255
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed50
Active, not recruiting11
Recruiting8
Unknown status8
Terminated6
Not yet recruiting2
Enrolling by invitation1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GlaxoSmithKline6
Cambridge University Hospitals NHS Foundation Trust5
Eli Lilly and Company5
Novartis Pharmaceuticals5
Imperial College London4
University of Edinburgh4
University of Oxford4
Amgen3
AstraZeneca3
St George's, University of London3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Atherosclerosis87
Cardiovascular Diseases23
Coronary Artery Disease20
Inflammation9
Stroke8
Hypercholesterolemia7
Myocardial Infarction7
Dyslipidemias6
Peripheral Arterial Disease6
Acute Coronary Syndrome5

Trials

Showing 1 to 25 of 87. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.